United States In Vitro Diagnostics Market Outlook to 2016

United States In Vitro Diagnostics Market Outlook to 2016

http://www.reportsandreports.com/market-reports/united-states-in-vitro-diagnostics-market-outlook-to-2016/ 

Summary

GlobalData’s new report, “US In Vitro Diagnostics Market Outlook to 2016” provides key market data on the US In Vitro Diagnostics (IVD) market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories - clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.Scope
  • Market size and company share data for In Vitro Diagnostics (IVD) market categories - clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology.
  • Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within seven market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016.
  • 2009 company shares and distribution shares data for each of the seven market categories.
  • Global corporate-level profiles of key companies operating within the US In Vitro Diagnostics (IVD) market.
  • Key players covered include Roche, Siemens Healthcare, Abbott, Beckman Coulter, Biomerieux, Ortho-Clinical Diagnostics, and Becton, Dickinson.
Reasons to buy
  • Develop business strategies by identifying the key market categories and segments poised for strong growth.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the US In Vitro Diagnostics (IVD) competitive landscape.
  • Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
1 Table of Contents
 
1.1 List of Tables
1.2 List of Figures
 
2 Introduction
2.1 What is This Report About?
 
3 In Vitro Diagnostics In United States
3.1 In Vitro Diagnostics, Market Segmentation
3.2 In Vitro Diagnostics, United States, Overall Revenue ($m), 2002-2016
3.3 In Vitro Diagnostics Market, United States, Revenue Mix ($m), 2009
3.4 In Vitro Diagnostics Market, United States, Category Contribution (%), 2009
3.5 In Vitro Diagnostics, United States, Company Share (2008-2009)
 
4 Clinical Chemistry In United States
4.1 Clinical Chemistry, Market Segmentation
4.2 Clinical Chemistry Market, United States, Revenue Mix ($m), 2009
4.3 Clinical Chemistry Market, United States, Category Contribution (%), 2009
4.4 Clinical Chemistry Overall Revenue (2002-2016)
4.5 Clinical Chemistry Distribution Share (2008-2009)
4.6 Clinical Chemistry, United States, Company Share (2008-2009)
 
5 Genetic Testing In United States
5.1 Genetic Testing, Market Segmentation
5.2 Genetic Testing Market, United States, Revenue Mix ($m), 2009
5.3 Genetic Testing Market, United States, Category Contribution (%), 2009
5.4 Genetic Testing Overall Revenue (2002-2016)
5.5 Genetic Testing Distribution Share (2008-2009)
5.6 Genetic Testing, United States, Company Share (2008-2009)
 
6 Haematology In United States
6.1 Haematology, Market Segmentation
6.2 Haematology Market, United States, Revenue Mix ($m), 2009
6.3 Haematology Market, United States, Category Contribution (%), 2009
6.4 Haematology Overall Revenue (2002-2016)
6.5 Haematology Distribution Share (2008-2009)
6.6 Haematology, United States, Company Share (2008-2009)
 
7 Histology And Cytology In United States
7.1 Histology and Cytology, Market Segmentation
7.2 Histology and Cytology Market, United States, Revenue Mix ($m), 2009
7.3 Histology and Cytology Market, United States, Category Contribution (%), 2009
7.4 Histology and Cytology Overall Revenue (2002-2016)
7.5 Histology and Cytology Distribution Share (2008-2009)
7.6 Histology and Cytology, United States, Company Share (2008-2009)
 
8 Immuno Chemistry In United States
8.1 Immuno Chemistry, Market Segmentation
8.2 Immuno Chemistry Market, United States, Revenue Mix ($m), 2009
8.3 Immuno Chemistry Market, United States, Category Contribution (%), 2009
8.4 Immuno Chemistry Overall Revenue (2002-2016)
8.5 Immuno Chemistry Distribution Share (2008-2009)
8.6 Immuno Chemistry, United States, Company Share (2008-2009)
 
9 Infectious Immunology In United States
9.1 Infectious Immunology, Market Segmentation
9.2 Infectious Immunology Market, United States, Revenue Mix ($m), 2009
9.3 Infectious Immunology Market, United States, Category Contribution (%), 2009
9.4 Infectious Immunology Overall Revenue (2002-2016)
9.5 Infectious Immunology Distribution Share (2008-2009)
9.6 Infectious Immunology, United States, Company Share (2008-2009)
 
10 Microbiology Culture In United States
10.1 Microbiology Culture, Market Segmentation
10.2 Microbiology Culture Market, United States, Revenue Mix ($m), 2009
10.3 Microbiology Culture Market, United States, Category Contribution (%), 2009
10.4 Microbiology Culture Overall Revenue (2002-2016)
10.5 Microbiology Culture Distribution Share (2008-2009)
10.6 Microbiology Culture, United States, Company Share (2008-2009)
 
11 Overview of Key Companies in United States In Vitro Diagnostics Market
11.1 Siemens Healthcare
11.2 Abbott Laboratories
11.3 F. Hoffmann-La Roche Ltd.
11.4 Beckman Coulter, Inc.
11.5 Becton, Dickinson and Company
11.6 Ortho-Clinical Diagnostics Inc.
11.7 Genzyme Corporation
11.8 Inverness Medical Innovations, Inc.
11.9 Baxter International Inc.
11.10 Thoratec Corporation
11.11 bioMerieux S.A.
11.12 Bio-Rad Laboratories, Inc.
11.13 Hologic, Inc.
11.14 OLYMPUS CORPORATION
11.15 Mindray Medical International Limited
11.16 Sysmex Corporation
11.17 Ventana Medical Systems, Inc.
11.18 DiaSorin S.p.A
11.19 Qiagen N.V.
11.20 Gen-Probe Incorporated
11.21 Phadia AB
11.22 Aethlon Medical, Inc.
11.23 Calypte Biomedical Corporation
11.24 Assay Designs, Inc.
11.25 BioTime, Inc.
11.26 Daxor Corporation
11.27 IRIS International, Inc.
11.28 Escalon Medical Corp.
11.29 Immucor, Inc.
11.30 Streck, Inc.
11.31 SurModics, Inc.
11.32 OraSure Technologies, Inc.
11.33 Meder International Group, Inc.
11.34 Micronics, Inc.
11.35 Instrumentation Laboratory
11.36 AdvanDx, Inc.
11.37 Biocare Medical LLC
11.38 Biocell Laboratories, Inc.
11.39 Protein Discovery, Inc.
11.40 Binax, Inc.
11.41 SYNTRON Bioresearch, Inc.
11.42 Bio/Data Corporation
11.43 Cartagen Molecular Systems, Inc.
11.44 Maxwell Sensors Inc.
11.45 Radient Pharmaceuticals Corporation
11.46 Milagen, Inc.
11.47 Lesanne Life Sciences, LLC
11.48 Exagen Diagnostics, Inc.
11.49 Celerus Diagnostics, Inc.
11.50 Biomedical Science Consulting Company, Inc.
11.51 BellBrook Labs
11.52 Monogen, Inc.
11.53 INOVA Diagnostics, Inc.
11.54 Haematologic Technologies, Inc.
11.55 EraGen Biosciences, Inc.
 
12 In Vitro Diagnostics Market Pipeline Products
12.1 Clinical Chemisty Market Pipeline Products
12.2 Immuno Chemistry Market Pipeline Products
12.3 Haematology Market Pipeline Products
12.4 Infectious Immunology Market Pipeline Products
12.5 Microbiology Culture Market Pipeline Products
12.6 Histology and Cytology Market Pipeline Products
12.7 Genetic Testing Market Pipeline Products
 
13 Financial Deals Landscape
13.1 Merger
13.2 Acquisition
 
14 Recent Developments
14.1 Strategy and Business Planning
14.2 Legal and Regulatory
14.3 Government and Public Interest
14.4 Product News
 
15 Appendix
15.1 Definitions of Markets Covered in the Report
15.2 Research Methodology
15.3 Secondary Research
15.4 Primary Research
15.5 Models
15.6 Forecasts
15.7 Expert Panels
15.8 GlobalData Consulting
15.9 Currency Conversion
15.10 Contact Us
15.11 Disclaimer
 
1.1 List of Tables
 
Table 1: In Vitro Diagnostics, United States, Overall Revenue ($m), 2002-2016
Table 2: In Vitro Diagnostics Market, United States, Category Contribution (%), 2009
Table 3: In Vitro Diagnostics, United States, Cross-Category Analysis, 2002-2016
Table 4: In Vitro Diagnostics, United States, Overall Revenue ($m), Historic, 2002-2009
Table 5: In Vitro Diagnostics, United States, Overall Revenue ($m), Forecast, 2009-2016
Table 6: In Vitro Diagnostics, United States, Company Share by Revenue ($m), 2008-2009
Table 7: Clinical Chemistry Market, United States, Category Contribution (%), 2009
Table 8: Clinical Chemistry, United States, Revenue ($m) by Segment, Historic, 2002-2009
Table 9: Clinical Chemistry, United States, Revenue ($m) by Segment, Forecast, 2009-2016
Table 10: Clinical Chemisty Analyzers, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 11: Clinical Chemisty Analyzers, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 12: Urine Analysis, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 13: Urine Analysis, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 14: Clinical Chemistry, United States, Distribution Share by Revenue ($m), 2008-2009
Table 15: Clinical Chemistry, United States, Company Share by Revenue ($m), 2008-2009
Table 16: Genetic Testing Market, United States, Category Contribution (%), 2009
Table 17: Genetic Testing, United States, Revenue ($m) by Segment, Historic, 2002-2009
Table 18: Genetic Testing, United States, Revenue ($m) by Segment, Forecast, 2009-2016
Table 19: Genetic Testing, United States, Distribution Share by Revenue ($m), 2008-2009
Table 20: Genetic Testing, United States, Company Share by Revenue ($m), 2008-2009
Table 21: Haematology Market, United States, Category Contribution (%), 2009
Table 22: Haematology, United States, Revenue ($m) by Segment, Historic, 2002-2009
Table 23: Haematology, United States, Revenue ($m) by Segment, Forecast, 2009-2016
Table 24: Haematology Reagents, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 25: Haematology Reagents, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 26: Immunohaematology, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 27: Immunohaematology, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 28: Haemostasis, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 29: Haemostasis, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 30: Haematology Rapid Tests, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 31: Haematology Rapid Tests, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 32: Haematology Cell Counters, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 33: Haematology Cell Counters, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 34: Haematology, United States, Distribution Share by Revenue ($m), 2008-2009
Table 35: Haematology, United States, Company Share by Revenue ($m), 2008-2009
Table 36: Histology and Cytology Market, United States, Category Contribution (%), 2009
Table 37: Histology And Cytology, United States, Revenue ($m) by Segment, Historic, 2002-2009
Table 38: Histology And Cytology, United States, Revenue ($m) by Segment, Forecast, 2009-2016
Table 39: Histology, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 40: Histology, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 41: Histology And Cytology, United States, Distribution Share by Revenue ($m), 2008-2009
Table 42: Histology And Cytology, United States, Company Share by Revenue ($m), 2008-2009
Table 43: Immuno Chemistry Market, United States, Category Contribution (%), 2009
Table 44: Immuno Chemistry, United States, Revenue ($m) by Segment, Historic, 2002-2009
Table 45: Immuno Chemistry, United States, Revenue ($m) by Segment, Forecast, 2009-2016
Table 46: Disease Specific Immunochemistry, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 47: Disease Specific Immunochemistry, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 48: Drug Related Testing, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 49: Drug Related Testing, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 50: Endocrinology Tests, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 51: Endocrinology Tests, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 52: Immunochemistry Analyzers, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 53: Immunochemistry Analyzers, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 54: Immuno Chemistry, United States, Distribution Share by Revenue ($m), 2008-2009
Table 55: Immuno Chemistry, United States, Company Share by Revenue ($m), 2008-2009
Table 56: Infectious Immunology Market, United States, Category Contribution (%), 2009
Table 57: Infectious Immunology, United States, Revenue ($m) by Segment, Historic, 2002-2009
Table 58: Infectious Immunology, United States, Revenue ($m) by Segment, Forecast, 2009-2016
Table 59: Infectious Immunology, United States, Distribution Share by Revenue ($m), 2008-2009
Table 60: Infectious Immunology, United States, Company Share by Revenue ($m), 2008-2009
Table 61: Microbiology Culture Market, United States, Category Contribution (%), 2009
Table 62: Microbiology Culture, United States, Revenue ($m) by Segment, Historic, 2002-2009
Table 63: Microbiology Culture, United States, Revenue ($m) by Segment, Forecast, 2009-2016
Table 64: Microbiology Analyzers, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Table 65: Microbiology Analyzers, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Table 66: Microbiology Culture, United States, Distribution Share by Revenue ($m), 2008-2009
Table 67: Microbiology Culture, United States, Company Share by Revenue ($m), 2008-2009
Table 68: Clinical Chemisty Market Pipeline Products
Table 69: Immuno Chemistry Market Pipeline Products
Table 70: Haematology Market Pipeline Products
Table 71: Infectious Immunology Market Pipeline Products
Table 72: Microbiology Culture Market Pipeline Products
Table 73: Histology and Cytology Market Pipeline Products
Table 74: Genetic Testing Market Pipeline Products
Table 75: Macada Holding To Merge With Undisclosed Company
Table 76: Carilion Clinic To Merge With Spectrum Laboratory Network
Table 77: Thermo Fisher Scientific Completes Acquisition Of Ahura Scientific
Table 78: PerkinElmer To Acquire Remaining Stake In AB SCIEX From Danaher
Table 79: Millipore Receives 79% Of Shareholders Approval For Its Acquisition By Merck
Table 80: Quidel Completes Acquisition Of Diagnostic HYBRIDS
Table 81: Inverness Medical Innovations To Acquire Kroll Laboratory Specialists From Kroll
Table 82: Medco Health Solutions Completes Acquisition Of DNA Direct
Table 83: Danaher Acquires Remaining 50% Interest In AB SCIEX From Life Technologies
Table 84: MDS Completes Sale Of MDS Analytical Technologies To Danaher
Table 85: QuantRx Biomedical To Acquire NuRx Pharmaceuticals
Table 86: Predictive Biosciences Acquires OncoDiagnostic Laboratory
Table 87: Bio-Rad Laboratories Completes Acquisition Of Medical Diagnostics Segment From Biotest
Table 88: USD to Local Currency, United States, Average Actual Rate 2002-2009
 
1.2 List of Figures
 
Figure 1: In Vitro Diagnostics, Market Segmentation
Figure 2: In Vitro Diagnostics, United States, Overall Revenue ($m), 2002-2016
Figure 3: In Vitro Diagnostics Market, United States, Revenue Mix ($m), 2009
Figure 4: In Vitro Diagnostics Market, United States, Category Contribution (%), 2009
Figure 5: In Vitro Diagnostics, United States, Cross-Category Analysis, 2002-2016
Figure 6: In Vitro Diagnostics, United States, Overall Revenue ($m), Historic, 2002-2009
Figure 7: In Vitro Diagnostics, United States, Overall Revenue ($m), Forecast, 2009-2016
Figure 8: In Vitro Diagnostics, United States, Company Share (%), 2009
Figure 9: Clinical Chemistry, Market Segmentation
Figure 10: Clinical Chemistry Market, United States, Revenue Mix ($m), 2009
Figure 11: Clinical Chemistry Market, United States, Category Contribution (%), 2009
Figure 12: Clinical Chemistry, United States, Revenue ($m) by Segment, Historic, 2002-2009
Figure 13: Clinical Chemistry, United States, Revenue ($m) by Segment, Forecast, 2009-2016
Figure 14: Clinical Chemisty Analyzers, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 15: Clinical Chemisty Analyzers, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 16: Urine Analysis, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 17: Urine Analysis, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 18: Clinical Chemistry, United States, Company Share (%), 2009
Figure 19: Genetic Testing, Market Segmentation
Figure 20: Genetic Testing Market, United States, Revenue Mix ($m), 2009
Figure 21: Genetic Testing Market, United States, Category Contribution (%), 2009
Figure 22: Genetic Testing, United States, Revenue ($m) by Segment, Historic, 2002-2009
Figure 23: Genetic Testing, United States, Revenue ($m) by Segment, Forecast, 2009-2016
Figure 24: Genetic Testing, United States, Company Share (%), 2009
Figure 25: Haematology, Market Segmentation
Figure 26: Haematology Market, United States, Revenue Mix ($m), 2009
Figure 27: Haematology Market, United States, Category Contribution (%), 2009
Figure 28: Haematology, United States, Revenue ($m) by Segment, Historic, 2002-2009
Figure 29: Haematology, United States, Revenue ($m) by Segment, Forecast, 2009-2016
Figure 30: Haematology Reagents, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 31: Haematology Reagents, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 32: Immunohaematology, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 33: Immunohaematology, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 34: Haemostasis, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 35: Haemostasis, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 36: Haematology Rapid Tests, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 37: Haematology Rapid Tests, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 38: Haematology Cell Counters, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 39: Haematology Cell Counters, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 40: Haematology, United States, Company Share (%), 2009
Figure 41: Histology and Cytology, Market Segmentation
Figure 42: Histology and Cytology Market, United States, Revenue Mix ($m), 2009
Figure 43: Histology and Cytology Market, United States, Category Contribution (%), 2009
Figure 44: Histology And Cytology, United States, Revenue ($m) by Segment, Historic, 2002-2009
Figure 45: Histology And Cytology, United States, Revenue ($m) by Segment, Forecast, 2009-2016
Figure 46: Histology, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 47: Histology, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 48: Histology And Cytology, United States, Company Share (%), 2009
Figure 49: Immuno Chemistry, Market Segmentation
Figure 50: Immuno Chemistry Market, United States, Revenue Mix ($m), 2009
Figure 51: Immuno Chemistry Market, United States, Category Contribution (%), 2009
Figure 52: Immuno Chemistry, United States, Revenue ($m) by Segment, Historic, 2002-2009
Figure 53: Immuno Chemistry, United States, Revenue ($m) by Segment, Forecast, 2009-2016
Figure 54: Disease Specific Immunochemistry, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 55: Disease Specific Immunochemistry, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 56: Drug Related Testing, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 57: Drug Related Testing, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 58: Endocrinology Tests, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 59: Endocrinology Tests, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 60: Immunochemistry Analyzers, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 61: Immunochemistry Analyzers, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 62: Immuno Chemistry, United States, Company Share (%), 2009
Figure 63: Infectious Immunology, Market Segmentation
Figure 64: Infectious Immunology Market, United States, Revenue Mix ($m), 2009
Figure 65: Infectious Immunology Market, United States, Category Contribution (%), 2009
Figure 66: Infectious Immunology, United States, Revenue ($m) by Segment, Historic, 2002-2009
Figure 67: Infectious Immunology, United States, Revenue ($m) by Segment, Forecast, 2009-2016
Figure 68: Infectious Immunology, United States, Company Share (%), 2009
Figure 69: Microbiology Culture, Market Segmentation
Figure 70: Microbiology Culture Market, United States, Revenue Mix ($m), 2009
Figure 71: Microbiology Culture Market, United States, Category Contribution (%), 2009
Figure 72: Microbiology Culture, United States, Revenue ($m) by Segment, Historic, 2002-2009
Figure 73: Microbiology Culture, United States, Revenue ($m) by Segment, Forecast, 2009-2016
Figure 74: Microbiology Analyzers, United States, Revenue ($m) by Sub-Segment, Historic, 2002-2009
Figure 75: Microbiology Analyzers, United States, Revenue ($m) by Sub-Segment, Forecast, 2009-2016
Figure 76: Microbiology Culture, United States, Company Share (%), 2009
Figure 77: Siemens Healthcare, Company Share (%),United States In Vitro Diagnostics Market, 2009
Figure 78: Abbott Laboratories, Company Share (%),United States In Vitro Diagnostics Market, 2009
Figure 79: F. Hoffmann-La Roche Ltd., Company Share (%),United States In Vitro Diagnostics Market, 2009
Figure 80: Beckman Coulter, Inc., Company Share (%),United States In Vitro Diagnostics Market, 2009
Figure 81: Becton, Dickinson and Company, Company Share (%),United States In Vitro Diagnostics Market, 2009
Figure 82: Ortho-Clinical Diagnostics Inc., Company Share (%),United States In Vitro Diagnostics Market, 2009
Figure 83: GlobalData Methodology
 http://www.mynewsdesk.com/us/pressroom/reports/pressrelease/view/united-states-in-vitro-diagnostics-market-outlook-to-2016-458202

Posted by a on
categories:

Subscribe via email

Enter your email address:

Delivered by FeedBurner

FeedBurner FeedCount

Blog Archive